Company Description
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.
It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions.
The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force.
The company was founded in 1989 and is headquartered in San Diego, California.
| Country | United States |
| Founded | 1989 |
| IPO Date | Jun 2, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 10,140 |
| CEO | Michael J. Farrell BE, MBA, SM |
Contact Details
Address: 9001 Spectrum Center Blvd. San Diego, California 92123 United States | |
| Phone | (858) 746-2400 |
| Website | resmed.com |
Stock Details
| Ticker Symbol | RMD |
| Exchange | NYSE |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000943819 |
| CUSIP Number | 761152107 |
| ISIN Number | US7611521078 |
| Employer ID | 98-0152841 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Michael J. Farrell BE, MBA, SM | Chief Executive Officer and Chairman |
| Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus and Director |
| Brett A. Sandercock | Chief Financial Officer |
| Robert A. Douglas | Special Advisor |
| Kaushik Ghoshal | Chief Commercial Officer - SaaS |
| Amy Wakeham | Chief Investor Relations Officer |
| Michael J. Rider | Chief Legal Officer |
| Jim Ellis | Chief Compliance Officer |
| Yvonne-Katrin Pucknat | Chief Marketing Officer |
| Vered Keisar | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 4, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Feb 22, 2024 | 144 | Filing |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 6, 2024 | 144 | Filing |
| Jan 25, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 25, 2024 | 10-Q | Quarterly Report |
| Jan 24, 2024 | 8-K | Current Report |
| Nov 27, 2023 | 144 | Filing |
| Nov 22, 2023 | 144 | Filing |